PH24979A - Liquid suspension for oral administration - Google Patents

Liquid suspension for oral administration

Info

Publication number
PH24979A
PH24979A PH37037A PH37037A PH24979A PH 24979 A PH24979 A PH 24979A PH 37037 A PH37037 A PH 37037A PH 37037 A PH37037 A PH 37037A PH 24979 A PH24979 A PH 24979A
Authority
PH
Philippines
Prior art keywords
active ingredient
oral administration
liquid suspension
particles
polymer
Prior art date
Application number
PH37037A
Other languages
English (en)
Inventor
Seamus Mulligan
Original Assignee
Elan Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Plc filed Critical Elan Corp Plc
Publication of PH24979A publication Critical patent/PH24979A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH37037A 1987-06-19 1988-06-09 Liquid suspension for oral administration PH24979A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE164587A IE59934B1 (en) 1987-06-19 1987-06-19 Liquid suspension for oral administration

Publications (1)

Publication Number Publication Date
PH24979A true PH24979A (en) 1990-12-26

Family

ID=11030020

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37037A PH24979A (en) 1987-06-19 1988-06-09 Liquid suspension for oral administration

Country Status (10)

Country Link
US (1) US5156842A (es)
EP (1) EP0295941B1 (es)
JP (1) JPS6416717A (es)
AT (1) ATE86851T1 (es)
CA (1) CA1314215C (es)
DE (1) DE3879286T2 (es)
DK (1) DK175812B1 (es)
ES (1) ES2054807T3 (es)
IE (1) IE59934B1 (es)
PH (1) PH24979A (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477289A4 (en) * 1989-06-13 1992-07-22 Abbott Laboratories Anhydrous oil-based liquid suspension for delivering a medicament
US5496535A (en) * 1991-04-12 1996-03-05 Alliance Pharmaceutical Corp. Fluorocarbon contrast media for use with MRI and radiographic imaging
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US5665382A (en) * 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of pharmaceutically active agents for in vivo delivery
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US6528067B1 (en) 1993-02-22 2003-03-04 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
AU673057B2 (en) * 1993-02-22 1996-10-24 Abraxis Bioscience, Llc Methods for (in vivo) delivery of biologics and compositionsuseful therefor
US5997904A (en) * 1993-02-22 1999-12-07 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
SI9400338A (en) * 1994-08-31 1996-04-30 Lek D D Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
BR9705470A (pt) * 1997-11-12 1999-07-06 Ind Quimica E Farmaceutica Sch Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
WO2001021147A1 (en) 1999-09-20 2001-03-29 Mastercare Diet and weight control gum and sucker
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
EP1337273A2 (en) 2000-11-28 2003-08-27 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
WO2003045357A1 (en) * 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
WO2003105810A1 (en) * 2002-06-14 2003-12-24 Andrx Corporation Pharmaceutical compositions for drugs having ph-dependentsolubility
US20040202696A1 (en) * 2003-04-14 2004-10-14 Cts Chemical Industries Ltd. Administration form for veterinary use
GB0308732D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Absorption enhancers
GB0308734D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Uptake of macromolecules
EP2535042A1 (en) * 2003-06-16 2012-12-19 ANDRX Pharmaceuticals LLC. Oral sustained-release composition comprising a macrolide
WO2011107855A2 (en) 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
FR3000400B1 (fr) * 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
US20170326161A1 (en) * 2015-12-10 2017-11-16 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (es) *
JPS4971127A (es) * 1972-11-18 1974-07-10
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4181721A (en) * 1975-10-27 1980-01-01 Schering Aktiengesellschaft Depot preparations in an oily, unsaturated solution for intramuscular injection
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
DE3309763A1 (de) * 1983-03-18 1984-09-20 Bayer Ag Stabile aminoglykosid-penicillin-injektionsformulierungen
JPS60193914A (ja) * 1984-03-14 1985-10-02 Kao Corp 含粒油性薬剤組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance

Also Published As

Publication number Publication date
EP0295941A2 (en) 1988-12-21
ATE86851T1 (de) 1993-04-15
DE3879286T2 (de) 1993-09-23
CA1314215C (en) 1993-03-09
DK175812B1 (da) 2005-03-07
IE59934B1 (en) 1994-05-04
DE3879286D1 (de) 1993-04-22
ES2054807T3 (es) 1994-08-16
US5156842A (en) 1992-10-20
DK333688D0 (da) 1988-06-17
DK333688A (da) 1988-12-20
EP0295941A3 (en) 1989-03-15
IE871645L (en) 1988-12-19
EP0295941B1 (en) 1993-03-17
JPS6416717A (en) 1989-01-20

Similar Documents

Publication Publication Date Title
EP0295941A3 (en) Liquid suspension for oral administration
AU2447288A (en) Drug carriers
AU2002892A (en) Porous inorganic ultrasound contrast agents
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
TW241194B (es)
GR3007481T3 (es)
AU8237082A (en) In-flight encapsulation of particles
AU6619686A (en) Time duration indicator systems, and also products containing such indicator systems having a limited duration of use or life
NZ313633A (en) Pharmaceutical composition containing rapamycin in a solid dispersion with a carrier medium
EP0314131A3 (en) Solid catalyst component for olefin polymerization
HU9200948D0 (en) Process for the stabilization of waterless suspensions
CA2029076A1 (en) Method for treating substrates
NZ219140A (en) Sustained release capsule containing active adsorbed on polymer
ES8702137A1 (es) Procedimiento de preparar una forma solidad de administracion farmaceutica para uso oral.
DE3478085D1 (en) Liquid prolonged release pharmaceutical formulations containing ionic constituents
DE3461889D1 (en) Drug with programmed release associating acetylsalicylic acid with dihydroergotamine
IL80182A (en) Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance
GR861872B (en) Pharmaceutical preparation with controlled and slowly active substance release and method for preparing it
AU2274488A (en) Low viscosity stable non-aqueous suspension containing organophilic clay and low density filler
CS622188A1 (en) Device for controllable axle's air suspension with tilting half-axles
CA2077334A1 (en) Marker device with permanent indicia
UA11843A1 (uk) Спосіб одержаhhя мікросферичhих частиhок двуокису кремhію